Even though AI-designed drugs aren’t yet a household term for FDA-approved, commercially available therapies, they are a ...

GenAI is generative, focusing on creating new content based on learned data, whether it’s text, images or molecular ...

Furthermore, researchers are exploring how AI can optimise clinical trial design and recruitment, analysing patient data to identify ideal candidates and accelerating the drug development process.

Over the last few decades, computer-aided drug design (CADD) has developed as an ... and the peer review process is supported by our industry-first AI review assistant (AIRA). As a junior researcher, ...

As we wrap up 2024, we are proud and excited to share a hand-picked selection of Pulitzer Center-supported stories that ...

COVID-19 & the Rise of Genetic Vaccines Messenger RNA was originally discovered in the 1960s. Scientists were immediately ...

Notably, the integration of artificial intelligence (AI) and machine learning into quantitative coronary ... discontinuously as a result of the emergence of multiple side branches) (16), the ...

Hong Kong-based Insilico Medicine said its generative artificial intelligence (AI) platforms helped it design a molecule that showed promise in a new drug for treating inflammatory bowel disease ...

MIT launched Boltz-1, an open-source AI model that rivals AlphaFold3, to enhance drug development and biomedical research.

Bristol Myers Squibb announced a collaboration agreement with three-year-old startup AI Proteins. According to its founder, ...